This federal contract award, valued at $1,662.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the provision of Dexcom G7 sensors, a type of continuous glucose monitoring device.
The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, across multiple therapeutic areas.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 2/27/25, 9:42 AM